Study Supports Early Postnatal Steroids for Extremely Preterm Infants Study Supports Early Postnatal Steroids for Extremely Preterm Infants

New data confirm the value of early low-dose prophylactic hydrocortisone in extremely preterm infants and suggest that those born after placental vascular disease may benefit the most.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news
More News: Health | Hydrocortisone | Study